Delivery Order SPE2DB22D1106-SPE2DB24FEZP2

Award Date 6/28/24
Potential Completion Date 7/1/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,402.97 firm fixed-price delivery order is for the supply of 4564616857 - ROCURONIUM 50 MG/5 ML VIAL 5ML. The contract has a completion date of May 16, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,967.80, is for the delivery of 4566747214 - ROCURONIUM 100 MG/10 ML VIAL 10ML. It is a firm fixed-price delivery order contract with a completion date of December 18, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $1,172.44 to provide the pharmaceutical product ROCURONIUM 50 MG/5 ML VIAL 5ML. This order falls under Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00, to deliver a wide range of pharmaceutical products and medical supplies to DLA Troop Support Medical...
This federal contract award is for the delivery of ROCURONIUM 100 MG/10 ML VIAL 10ML to the Medical Supply Chain, a component of the Defense Logistics Agency (DLA). The $1,128.03 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 9, 2024, with a final completion date of August 12, 2024. This contract is not associated with a set-aside program. Amerisourcebergen holds several indefinite delivery contracts (IDCs) with the DLA...
This is a $1,105.56 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4567367457 ROCURONIUM 100 MG/10 ML VIAL 10ML, a critical medical commodity, to support federal healthcare programs. The award is part of AmerisourceBergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, identified as SPE2DB22D3301 and SPE2DB24FZ1AS, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,760.40, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,003.66 firm fixed-price delivery order is for the supply of 4,566,133,818 units of Rocuronium 50 mg/5 ml vial, a critical medical product used in healthcare settings. The award is not designated with a set-aside and represents an open competition. It is part of a larger $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of 100 mg/10 mL vials of the pharmaceutical product rocuronium. The contract was awarded by the Defense Logistics Agency (DLA), an agency of the U.S. Department of Defense, to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation. The contract has a total ceiling value of $1,819.11 and is a firm fixed-price delivery order with a completion date of May 7, 2024. It does...
This federal contract award, identified as SPE2DB20D7066|SPE2DB24FC2LT, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The $1,014.29 firm fixed-price delivery order is for the supply of 4565259157 - ROCURONIUM 100 MG/10 ML VIAL 10ML, a critical medical commodity. The contract has an ultimate completion date of July 29, 2024 and is not designated as a set-aside. Amerisourcebergen, a major...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Rocuronium 50 mg/5 ml vials, a critical medical supply. The total ceiling value of the contract is $1,421.76, and it has a period of performance through February 19, 2025. This contract award is not designated as a set-aside. AmerisourceBergen holds...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FEZP2
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of 4565030949 - ROCURONIUM 100 MG/10 ML VIAL 10ML. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,187.40 and an ultimate completion date of July 1, 2024.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award was not set aside for any specific business category.

Generated 9/27/24, 9:12 AM